Cargando…
Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201853/ https://www.ncbi.nlm.nih.gov/pubmed/30405879 http://dx.doi.org/10.18632/oncotarget.26207 |
| _version_ | 1783365583768649728 |
|---|---|
| author | Mizrahi, Jonathan D. Overman, Michael J. |
| author_facet | Mizrahi, Jonathan D. Overman, Michael J. |
| author_sort | Mizrahi, Jonathan D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6201853 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62018532018-11-07 Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury Mizrahi, Jonathan D. Overman, Michael J. Oncotarget Editorial Impact Journals LLC 2018-10-09 /pmc/articles/PMC6201853/ /pubmed/30405879 http://dx.doi.org/10.18632/oncotarget.26207 Text en Copyright: © 2018 Mizrahi et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Mizrahi, Jonathan D. Overman, Michael J. Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury |
| title | Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury |
| title_full | Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury |
| title_fullStr | Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury |
| title_full_unstemmed | Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury |
| title_short | Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury |
| title_sort | bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201853/ https://www.ncbi.nlm.nih.gov/pubmed/30405879 http://dx.doi.org/10.18632/oncotarget.26207 |
| work_keys_str_mv | AT mizrahijonathand bevacizumabasachemoprotectantreducingoxaliplatininducedhepaticsinusoidalinjury AT overmanmichaelj bevacizumabasachemoprotectantreducingoxaliplatininducedhepaticsinusoidalinjury |